Cargando…
Phosphocitrate Is Potentially a Disease-Modifying Drug for Noncrystal-Associated Osteoarthritis
Phosphocitrate (PC), a calcification inhibitor, inhibits the development of crystal-associated osteoarthritis (OA) in Hartley guinea pigs. However, the molecular mechanisms underlying its disease-modifying effect remain elusive. This study sought to test the hypothesis that PC has calcium crystal-in...
Autores principales: | Sun, Yubo, Mauerhan, David R., Franklin, Atiya M., Norton, James, Hanley, Edward N., Gruber, Helen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595112/ https://www.ncbi.nlm.nih.gov/pubmed/23555081 http://dx.doi.org/10.1155/2013/326267 |
Ejemplares similares
-
Biological Effects of Phosphocitrate on Osteoarthritic Articular Chondrocytes
por: Sun, Yubo, et al.
Publicado: (2017) -
Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis
por: Sun, Yubo, et al.
Publicado: (2015) -
Expression of Phosphocitrate-Targeted Genes in Osteoarthritis Menisci
por: Sun, Yubo, et al.
Publicado: (2014) -
Biological Activities of Phosphocitrate: A Potential Meniscal Protective Agent
por: Sun, Yubo, et al.
Publicado: (2013) -
The role of inhibition by phosphocitrate and its analogue in chondrocyte differentiation and subchondral bone advance in Hartley guinea pigs
por: Sun, Yubo, et al.
Publicado: (2018)